ChromaDex CorporationCDXCNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, above historical average, slight contraction.
Left:
||||
Year-over-year research & development expense growth
Latest
14.55%
↑ 69% above average
Average (39q)
8.63%
Historical baseline
Range
High:115.38%
Low:-37.18%
CAGR
-5.2%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | 14.55% |
| Q2 2025 | 24.56% |
| Q1 2025 | -4.33% |
| Q4 2024 | 1.94% |
| Q3 2024 | -1.98% |
| Q2 2024 | -37.18% |
| Q1 2024 | 80.76% |
| Q4 2023 | -6.61% |
| Q3 2023 | -9.08% |
| Q2 2023 | 14.42% |
| Q1 2023 | -6.72% |
| Q4 2022 | 4.49% |
| Q3 2022 | -1.69% |
| Q2 2022 | 15.49% |
| Q1 2022 | 3.16% |
| Q4 2021 | 4.92% |
| Q3 2021 | -0.80% |
| Q2 2021 | 21.84% |
| Q1 2021 | -16.85% |
| Q4 2020 | 12.61% |
| Q3 2020 | -6.58% |
| Q2 2020 | 2.50% |
| Q1 2020 | -19.32% |
| Q4 2019 | 9.10% |
| Q3 2019 | -2.34% |
| Q2 2019 | -8.48% |
| Q1 2019 | -8.39% |
| Q4 2018 | -5.56% |
| Q3 2018 | -4.53% |
| Q2 2018 | -1.74% |
| Q1 2018 | -0.96% |
| Q4 2017 | 39.58% |
| Q3 2017 | 22.48% |
| Q3 2017 | 27.97% |
| Q2 2017 | 24.34% |
| Q4 2016 | -30.88% |
| Q4 2016 | 2.80% |
| Q3 2016 | 61.98% |
| Q2 2016 | 14.19% |
| Q1 2016 | 115.38% |